FDA Inspection 1271223 — Janssen Pharmaceuticals, Inc
The FDA completed an inspection of Janssen Pharmaceuticals, Inc on Aug 14, 2025 in Titusville, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 14, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Titusville, NJ (United States)